The trademark application CONTINULON was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on January 8, 2012, and it was registered by office on April 16, 2012 without any oppositions.
The application was filed in English (Italian was selected as the second language).
The renewal of the trademark was recorded by the office on July 13, 2022.
of the trademark registration was recorded on July 13, 2022. Change of name and professional address of the trademark registration was recorded on December 19, 2018. Appointment and Replacement of representative of the trademark registration was recorded on April 24, 2019.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis, prevention and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders
Antipsychotic pharmaceutical preparations
Antidepressants
None of the afore goods being in the nature of preparations for pain relief or analgesics.